A new test for early detection of esophageal cancer using a swallowable capsule.
An accurate, affordable, and transferable assay for minimally invasive detection of esophageal squamous cell carcinoma (ESCC) in Africa and the United States
This study is working on a simple and affordable test that uses a swallowable sponge to check for early signs of esophageal cancer, making it easier for people in the U.S. and Uganda to get diagnosed and treated sooner.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Capsulomics, LLC NIH-funded |
| Lab location | 1 site (Baltimore, UNITED STATES) |
| Project ID | NIH-10921933 on NIH RePORTER |
What this research studies
This research focuses on developing a low-cost and accurate diagnostic test for esophageal squamous cell carcinoma (ESCC) using a noninvasive swallowable sponge-capsule device. The test utilizes specific DNA biomarkers from esophageal cells to detect cancer at an early stage, which is crucial for improving survival rates. The project aims to validate this diagnostic method through extensive testing and to make it accessible in both the United States and Uganda, addressing a significant healthcare need in low- to moderate-income countries.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for esophageal cancer, particularly those in low- to moderate-income countries and those with symptoms suggestive of esophageal issues.
Not a fit: Patients with other types of esophageal cancer or those who do not meet the risk criteria for ESCC may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of esophageal cancer, significantly improving treatment outcomes and survival rates for patients.
How similar studies have performed: Previous research has shown promising results with similar noninvasive diagnostic approaches, indicating potential for success in this novel application.
Where this research is happening
Baltimore, UNITED STATES
- Capsulomics, LLC — Baltimore, United States (Active)
Researchers
- Principal investigator: Laun, Sarah — Capsulomics, LLC
- Study coordinator: Laun, Sarah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.